Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 81.55
-1.66 (-1.99%)
Oct 1, 2026, 3:14 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 2.95 billion as of October 2, 2026. Its market cap has decreased by -14.01% in one year.
Market Cap
2.95B
Enterprise Value
3.40B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
81.55
ChartMarket Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 2.95B, an increase of 900.68%. That is a compound annual growth rate of 10.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 2.95B | 8.85% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 613.87B |
| Anthem Biosciences | 489.84B |
| OneSource Specialty Pharma | 181.52B |
| Concord Biotech | 147.58B |
| Blue Jet Healthcare | 104.03B |
| Supriya Lifescience | 79.28B |
| Zota Health Care | 45.03B |
| Dishman Carbogen Amcis | 25.30B |